๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
28.00
-1.35 (-4.60%)
Nov 20, 2026, 1:30 PM CST

Nang Kuang Pharmaceutical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,0882,1622,2002,1501,9401,780
Revenue Growth
-6.10%-1.71%2.31%10.81%9.01%1.44%
Gross Profit
723.04768.86747.79755.56694.9594.47
Operating Income
253.37295.67310.22259.84321.67254.48
Net Income
188.31244.41243.41198.41352196.11
Earnings Per Share
1.852.412.401.963.481.94
EPS Growth
-27.13%0.42%22.45%-43.68%79.38%7.18%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Countries
67.664.3154.4534.8226.62
Taiwan
1,7031,6121,4211,3061,173
Mainland China
209.24239.74407.41184.15362.6
Japan
101.06190.08207.07240.9395.64
United States
81.4593.2460.37174.14122.59
Total
2,1622,2002,1501,9401,780

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
178.22345.67301.54378.48402.51418.41
Total Debt
762.72655.69638.23705.56409.13532.81
Net Cash (Debt)
-584.5-310.02-336.69-327.08-6.62-114.4
Net Cash Growth
------
Net Cash Per Share
-5.76-3.06-3.33-3.23-0.07-1.13

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
256.34464.08466.43342.61369.19556.63
Capital Expenditures
-250.49-277.82-524.6-297.51-93.84-156.05
Free Cash Flow
5.85186.25-58.1745.1275.35400.58
Free Cash Flow Growth
198.93%---83.62%-31.26%558.08%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
34.62%35.56%33.99%35.14%35.81%33.40%
Operating Margin
12.13%13.67%14.10%12.08%16.58%14.30%
Pretax Margin
10.71%13.47%13.78%9.94%21.16%13.19%
Profit Margin
9.02%11.30%11.06%9.23%18.14%11.02%
FCF Margin
0.28%8.61%-2.64%2.10%14.19%22.50%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.600-1.6002.0002.3001.800
Dividend Per Share Growth
0%--20.00%-13.04%27.78%12.50%
Dividend Yield
5.71%-3.89%3.75%3.60%4.67%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
15.1315.4117.0727.1318.3319.83
Forward PE
-14.9217.9519.6821.3014.55
P/FCF Ratio
483.3620.22-119.3623.449.71
PS Ratio
1.351.741.892.503.332.18